Skip to content

Modified Environment for Agitation in Patients With TBI

Modified Environment for Agitation in Patients With Traumatic Brain Injury: a Controlled Multicenter

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02524067
Acronym
ABS
Enrollment
20
Registered
2015-08-14
Start date
2015-09-30
Completion date
2018-05-31
Last updated
2018-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Agitated Behaviour, Traumatic Brain Injury (TBI)

Brief summary

This study examines the effect of an intervention consisting of dynamic circadian light and sound therapy, as well as systematic information on sleep pattern, agitated behavior and functioning level.

Interventions

BEHAVIORALMultifactorial circadian concept

Circadian light, systematic information, music, individual foreclosure

Sponsors

Aarhus University Hospital
CollaboratorOTHER
Regionshospitalet Hammel Neurocenter
CollaboratorOTHER
Rigshospitalet, Denmark
CollaboratorOTHER
Glostrup University Hospital, Copenhagen
CollaboratorOTHER
University of Aarhus
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with moderate and severe Traumatic Brain Injury (TBI) * Diagnosed with Glasgow Coma Score (GCS) lower than 13-

Exclusion criteria

* Patients with psychiatric diagnose and not speaking danish -

Design outcomes

Primary

MeasureTime frame
Agitation on Agitated Behaviour Scale (ABS)One year
Functional abilities on the Early Functional Abilities Scale (EFA)One year
Functional abilities on the Glasgow Outcome Extend Scale12 month after admission

Secondary

MeasureTime frame
Orientation and duration of post-traumatic amnesia on the Galveston Orientation and Amnesia Scale (GOAT)One year

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026